Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Gardiner, Chris ^a   Tannetta, Dionne S ^a   Simms, Carol A ^a   Harrison, Paul ^b   Redman, Christopher W G ^a   Sargent, Ian L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; RECOMBINANT PROTEIN;

ADULT; ARTICLE; CELL VACUOLE; CESAREAN SECTION; CLINICAL ARTICLE; ENZYME ANALYSIS; ENZYME SYNTHESIS; FEMALE; HEMOSTASIS; HUMAN; HUMAN CELL; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANT WOMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; SYNCYTIOTROPHOBLAST; SYNCYTIOTROPHOBLAST MICROVESICLE; THROMBOCYTE POOR PLASMA; BLOOD; DRUG EFFECT; METABOLISM; PATHOLOGY; PREGNANCY; TROPHOBLAST;

ADULT; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RECOMBINANT PROTEINS; THROMBIN; THROMBOPLASTIN; TROPHOBLASTS;

EID: 80054693048     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026313     Document Type: Article

References (51)

1. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R, (2010) Pre-eclampsia. Lancet 376: 631-644 S0140-6736(10)60279-6 [pii];10.1016/S0140-6736(10)60279-6 [doi].
2. Hellgren M, (2003) Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 29: 125-130 10.1055/s-2003-38897 [doi].
3. Redman CW, Sargent IL, (2005) Latest advances in understanding preeclampsia. Science 308: 1592-1594 308/5728/1592 [pii];10.1126/science.1111726 [doi].
4. Rosenkranz A, Hiden M, Leschnik B, Weiss EC, Schlembach D, et al. (2008) Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost 99: 331-337 08020331 [pii];10.1160/TH07-05-0359 [doi].
5. Bonnar J, McNicol GP, Douglas AS, (1971) Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia. Br Med J 2: 12-16.
6. Mackman N, (2009) The many faces of tissue factor. J Thromb Haemost 7 (Suppl 1): 136-139 JTH3368 [pii];10.1111/j.1538-7836.2009.03368.x [doi].
7. Ruf W, Dorfleutner A, Riewald M, (2003) Specificity of coagulation factor signaling. J Thromb Haemost 1: 1495-1503 300 [pii].
8. Monroe DM, Key NS, (2007) The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking. J Thromb Haemost 5: 1097-1105 JTH2435 [pii];10.1111/j.1538-7836.2007.02435.x [doi].
9. Lanir N, Aharon A, Brenner B, (2003) Procoagulant and anticoagulant mechanisms in human placenta. Semin Thromb Hemost 29: 175-184 10.1055/s-2003-38833 [doi].
10. Butenas S, Orfeo T, Mann KG, (2009) Tissue factor in coagulation: Which? Where? When? Arterioscler Thromb Vasc Biol 29: 1989-1996 ATVBAHA.108.177402 [pii];10.1161/ATVBAHA.108.177402 [doi].
11. So AK, Varisco PA, Kemkes-Matthes B, Herkenne-Morard C, Chobaz-Peclat V, et al. (2003) Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. J Thromb Haemost 1: 2510-2515 462 [pii].
12. Ollivier V, Wang J, Manly D, Machlus KR, Wolberg AS, et al. (2010) Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay. Thromb Res 125: 90-96 S0049-3848(09)00125-X [pii];10.1016/j.thromres.2009.03.003 [doi].
13. Key NS, Mackman N, (2010) Tissue factor and its measurement in whole blood, plasma, and microparticles. Semin Thromb Hemost 36: 865-875 10.1055/s-0030-1267040 [doi].
14. Butenas S, Bouchard BA, Brummel-Ziedins KE, Parhami-Seren B, Mann KG, (2005) Tissue factor activity in whole blood. Blood 105: 2764-2770 2004-09-3567 [pii];10.1182/blood-2004-09-3567 [doi].
15. Biro E, Sturk-Maquelin KN, Vogel GM, Meuleman DG, Smit MJ, et al. (2003) Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 1: 2561-2568 456 [pii].
16. Mackman N, Tilley RE, Key NS, (2007) Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 27: 1687-1693 ATVBAHA.107.141911 [pii];10.1161/ATVBAHA.107.141911 [doi].
17. Reverdiau P, Jarousseau AC, Thibault G, Khalfoun B, Watier H, et al. (1995) Tissue factor activity of syncytiotrophoblast plasma membranes and tumoral trophoblast cells in culture. Thromb Haemost 73: 49-54.
18. Teng YC, Lin QD, Lin JH, Ding CW, Zuo Y, (2009) Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts. J Perinat Med 37: 343-348 10.1515/JPM.2009.060 [doi].
19. Aharon A, Brenner B, Katz T, Miyagi Y, Lanir N, (2004) Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis. Thromb Haemost 92: 776-786 04100776 [pii];10.1267/THRO04040776 [doi].
20. Faulk WP, Labarrere CA, Carson SD, (1990) Tissue factor: identification and characterization of cell types in human placentae. Blood 76: 86-96.
21. Lakasing L, Campa JS, Poston R, Khamashta MA, Poston L, (1999) Normal expression of tissue factor, thrombomodulin, and annexin V in placentas from women with antiphospholipid syndrome. Am J Obstet Gynecol 181: 180-189 S0002937899004305 [pii].
22. Fleck RA, Rao LV, Rapaport SI, Varki N, (1990) Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 59: 421-437.
23. Teng Y, Jiang R, Lin Q, Ding C, Ye Z, (2010) The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients. Thromb Res 126: e41-e45 S0049-3848(10)00159-3 [pii];10.1016/j.thromres.2010.02.012 [doi].
24. Redecha P, van RN, Torry D, Girardi G, (2009) Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury. Blood 113: 4101-4109 blood-2008-12-194258 [pii];10.1182/blood-2008-12-194258 [doi].
25. Osterud B, (2010) Tissue factor expression in blood cells. Thromb Res 125 (Suppl 1): S31-S34 S0049-3848(10)00085-X [pii];10.1016/j.thromres.2010.01.032 [doi].
26. Lok CA, van der Post JA, Sargent IL, Hau CM, Sturk A, et al. (2008) Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hypertens Pregnancy 27: 344-360 905430628 [pii];10.1080/10641950801955733 [doi].
27. Knight M, Redman CW, Linton EA, Sargent IL, (1998) Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol 105: 632-640.
28. Goswami D, Tannetta DS, Magee LA, Fuchisawa A, Redman CW, et al. (2006) Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 27: 56-61 S0143-4004(04)00293-0 [pii];10.1016/j.placenta.2004.11.007 [doi].
29. Freeman DJ, Tham K, Brown EA, Rumley A, Lowe GD, et al. (2008) Fetal corticotrophin-releasing hormone mRNA, but not phosphatidylserine-exposing microparticles, in maternal plasma are associated with factor VII activity in pre-eclampsia. J Thromb Haemost 6: 421-427 JTH2882 [pii];10.1111/j.1538-7836.2007.02882.x [doi].
30. Ng EK, Leung TN, Tsui NB, Lau TK, Panesar NS, et al. (2003) The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin Chem 49: 727-731.
31. Aharon A, Katzenell S, Tamari T, Brenner B, (2009) Microparticles bearing tissue factor and tissue factor pathway inhibitor in gestational vascular complications. J Thromb Haemost 7: 1047-1050 JTH3342 [pii];10.1111/j.1538-7836.2009.03342.x [doi].
32. Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW, (2007) Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 178: 5949-5956 178/9/5949 [pii].
33. Rousseau A, Favier R, Van DP, (2009) Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia? Eur J Obstet Gynecol Reprod Biol 146: 46-49 S0301-2115(09)00373-X [pii];10.1016/j.ejogrb.2009.06.001 [doi].
34. Bellart J, Gilabert R, Angles A, Piera V, Miralles RM, et al. (1999) Tissue factor levels and high ratio of fibrinopeptide A:D-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia. Br J Obstet Gynaecol 106: 594-597.
35. Estelles A, Gilabert J, Grancha S, Yamamoto K, Thinnes T, et al. (1998) Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia. Thromb Haemost 79: 500-508 98030500 [pii].
36. Lok CA, Boing AN, Sargent IL, Sooranna SR, van der Post JA, et al. (2008) Circulating platelet-derived and placenta-derived microparticles expose Flt-1 in preeclampsia. Reprod Sci 15: 1002-1010 1933719108324133 [pii];10.1177/1933719108324133 [doi].
37. Rank A, Nieuwland R, Crispin A, Grutzner S, Iberer M, et al. (2011) Clearance of platelet microparticles in vivo. Platelets 22: 111-116 10.3109/09537104.2010.520373 [doi].
38. Guller S, Tang Z, Ma YY, Di SS, Sager R, et al. (2011) Protein composition of microparticles shed from human placenta during placental perfusion: Potential role in angiogenesis and fibrinolysis in preeclampsia. Placenta 32: 63-69 S0143-4004(10)00400-5 [pii];10.1016/j.placenta.2010.10.011 [doi].
39. VanWijk MJ, Boer K, Berckmans RJ, Meijers JC, van der Post JA, et al. (2002) Enhanced coagulation activation in preeclampsia: the role of APC resistance, microparticles and other plasma constituents. Thromb Haemost 88: 415-420 10.1267/THRO88030415 [doi];02090415 [pii].
40. Douglas JT, Shah M, Lowe GD, Belch JJ, Forbes CD, et al. (1982) Plasma fibrinopeptide A and beta-thromboglobulin in pre-eclampsia and pregnancy hypertension. Thromb Haemost 47: 54-55.
41. de BK, ten Cate JW, Sturk A, Borm JJ, Treffers PE, (1989) Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 160: 95-100 0002-9378(89)90096-3 [pii].
42. Bonnar J, Redman CW, Denson KW, (1976) The role of coagulation and fibrinolysis in preeclampsia. Perspect Nephrol Hypertens 5: 85-93.
43. Cadroy Y, Grandjean H, Pichon J, Desprats R, Berrebi A, et al. (1993) Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol 100: 416-420.
44. Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J, (1994) Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol 101: 488-492.
45. Girardi G, (2010) Role of tissue factor in feto-maternal development: a xiphos. J Thromb Haemost 10.1111/j.1538-7836.2010.04135.x [doi].
46. Erez O, Romero R, Kim SS, Kim JS, Kim YM, et al. (2008) Over-expression of the thrombin receptor (PAR-1) in the placenta in preeclampsia: a mechanism for the intersection of coagulation and inflammation. J Matern Fetal Neonatal Med 21: 345-355 792342961 [pii];10.1080/14767050802034859 [doi].
47. Mutter WP, Karumanchi SA, (2008) Molecular mechanisms of preeclampsia. Microvasc Res 75: 1-8 S0026-2862(07)00057-X [pii];10.1016/j.mvr.2007.04.009 [doi].
48. Krudysz-Amblo J, Jennings ME, Mann KG, Butenas S, (2010) Carbohydrates and activity of natural and recombinant tissue factor. J Biol Chem 285: 3371-3382 M109.055178 [pii];10.1074/jbc.M109.055178 [doi].
49. Kumpel B, King MJ, Sooranna S, Jackson D, Eastlake J, et al. (2008) Phenotype and mRNA expression of syncytiotrophoblast microparticles isolated from human placenta. Ann N Y Acad Sci 1137: 144-147 NYAS1137017 [pii];10.1196/annals.1448.017 [doi].
50. Hemker HC, Giesen P, Al DR, Regnault V, de SE, et al. (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 33: 4-15 10.1159/000071636 [doi];PHT2003033001004 [pii].
51. Luddington R, Baglin T, (2004) Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. J Thromb Haemost 2: 1954-1959 JTH964 [pii];10.1111/j.1538-7836.2004.00964.x [doi].